1) erlotinib
厄罗替尼
1.
The advances of erlotinib in cancer treatment
厄罗替尼靶向治疗肿瘤临床研究进展
2.
Objective:To evaluate the efficacy of erlotinib on advanced NSCLC,and observe its adverse events.
目的:观察厄罗替尼治疗晚期非小细胞肺癌(NSCLC)患者的疗效和不良反应。
2) Erlotinib
厄洛替尼
1.
Effects of Cetuximab Combined Erlotinib on Proliferation of Human Hepatocellular Carcinoma Cell Lines HepG2 and Bel-7402;
西妥昔单抗联合厄洛替尼对人肝癌细胞的体外抑制作用
2.
Preliminary Results of Erlotinib Concomitant with Radiation Therapy for Non-small Cell Lung Cancer Patients with Multiple Brain Metastases;
厄洛替尼联合全脑放射治疗非小细胞肺癌多发脑转移的初步观察
3.
New drug for non-small cell lung cancer target therapy-erlotinib;
非小细胞肺癌靶向治疗新药——厄洛替尼
3) nilotinib
尼罗替尼
1.
Pharmacology and clinical evaluation of nilotinib,a Bcr-Abl tyrosine kinase inhibitor;
Bcr-Abl激酶抑制剂尼罗替尼的药理与临床评价
2.
After deprotection, the antitumor agent nilotinib was obtained with an overall yield of 40% based on compound 5.
另用3-氨基-4-甲基苯甲酸乙酯(5)与氨腈成胍6,6与3-二甲胺基-1-(3-吡啶基)-2-丙烯-1-酮环合得4-甲基-3-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯甲酸乙酯(8),8经叔丁氧羰基保护、水解,再与4经酰胺化、脱保护后得到尼罗替尼,总收率40%(以5计)。
4) erlotinib
埃罗替尼
1.
Relationship between efficacy and erlotinib-induced rash;
埃罗替尼的疗效与其所致皮疹的相关性
2.
Synthesis and antitumor activities of erlotinib derivatives;
埃罗替尼衍生物的合成及抗肿瘤活性
3.
Effects of gemcitabine plus erlotinib on the proliferation of pancreatic cancer cells
吉西他滨与埃罗替尼联用对人胰腺癌细胞生长的影响
5) Synthesis of Nilotinib
尼罗替尼的合成
6) Erlotinib hydrochloride
盐酸埃罗替尼
补充资料：刑厄
1.灾难。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条